Sirnaomics Ltd. (HK:2257) has released an update.
Sirnaomics Ltd., a company specializing in RNAi therapeutics, has announced the composition of its board of directors, which includes both executive and non-executive members, as well as the organization of its three board committees. The board is led by Dr. Yang Lu, who serves as Chairman, President, and CEO, and is supported by a mix of directors who are assigned to committees focused on audit, nomination, and remuneration.
For further insights into HK:2257 stock, check out TipRanks’ Stock Analysis page.
